Nostradamus C.3 Q.38: The corporation that uses space science to conduct cancer experiments on captives.
It is normal for any reader to form a quick view as
to what they are seeing which can actually prevent the understanding of
what is obvious when read in a different context. This verse is a clear
example where the anagrams for most omens will misdirect
attention to the wrong realm. When the anagrams of this verse are read
within the context of modern medical treatments such terms become
uncomfortably familiar. The scenario in the anagrams emerges of a
corporate group mistreating captured people in the pursuit of cancer
research. The terms used in building this description are not only
modern but of a time that lies ahead of us. A key anagram is that for
astronomic and it is backed by another for astrionic
which is the science and technology behind space electronics. There is
also a series suggesting modern corporations involved in genetic science
lie behind the events in the text. These include consortium, consortia
and inter-corporate as well as genealoguist and genesis. The branch of
science in which they are involved is the study of cancers and the
collection of anagrams and words in the text imply it is an involuntary
set of experiments to which they are subjected. There is even
minute detail about the way the experiments are conducted using laser
beams and accurate recording devices to see any cancerous regrowth.
C.3 Q.38
The Gallic people and a foreign nation La gent Gauloi$e et nation e$trange
Anagram Clusters contained in N's French text.
|
This site is the means by which I communicate with readers of my web-site and books on Nostradamus' Prophecies.
Wednesday, July 30, 2014
Nostradamus C.3 Q.38: The corporation that uses space science to conduct cancer experiments on captives
Labels:
'C3 Q 38',
Antoinete,
astionic,
astronomic,
cancerous,
cancers,
consortium,
eugenesis,
Gaulonite,
genealogist echoed,
genesis,
gridder,
gunneries,
inter-corporate,
intonate,
laser,
Louise,
Nestorian,
record.,
resonating
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment